- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | Chordate Medical Holding AB: Chordate's application for delisting has been approved | 86 | GlobeNewswire (Europe) | Chordate Medical Holding AB (publ) ("Chordate" or "the Company") application for delisting of the Company's ordinary shares with ISIN SE0022726139 and preference shares with ISIN SE0023848619 has now... ► Artikel lesen | |
| 18.02. | Chordate Medical Holding AB: Chordate applies for delisting | 132 | GlobeNewswire (Europe) | Following the general meeting of Chordate Medical Holding AB (publ) ("Chordate" or "the Company") resolution to delist the Company's shares and to liquidate the Company, the liquidator has decided to... ► Artikel lesen | |
| 16.01. | Chordate Medical Holding AB: Chordate announces updated timetable for delisting | 100 | GlobeNewswire (Europe) | The general meeting of Chordate Medical Holding AB (publ) ("Chordate" or "the Company") resolved at an extraordinary general meeting on 8 December 2025, among other things, to delist the Company's shares.... ► Artikel lesen | |
| 16.12.25 | Chordate Medical Holding AB: Chordate Medical terminates the liquidity guarantee for the common share | 188 | GlobeNewswire (Europe) | Chordate Medical hereby announces that the company has terminated the agreement with Lago Kapital regarding the assignment as liquidity provider for the common share CMH.
The purpose of the liquidity... ► Artikel lesen | |
| 08.12.25 | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 126 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on December 8, 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals... ► Artikel lesen | |
| 19.11.25 | Chordate Medical Holding AB (publ) receives observation status | 161 | GlobeNewswire | Yesterday, November 18, 2025, Chordate Medical Holding AB (publ) (the "Company") disclosed a notice convening an extraordinary general meeting of the Company's shareholders, with a proposal for voluntary... ► Artikel lesen | |
| CHORDATE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 21.08.25 | Chordate Medical Holding AB: Chordate Announces Cost Reduction and Focus on Company Sale | 184 | GlobeNewswire (Europe) | Chordate Medical Holding AB (Publ.) (the "Company") has adopted a cost reduction program that includes focusing activities on the continued ambition to sell the Company. Together with the recently completed... ► Artikel lesen | |
| 19.08.25 | Chordate Medical Holding AB: Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010 | 211 | GlobeNewswire (Europe) | Since this Post Market Surveillance study is open-label (uncontrolled), it is possible - and the sponsor's responsibility - to actively monitor study data during the ongoing trial. It is both scientifically... ► Artikel lesen | |
| 17.07.25 | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 293 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on 17 July 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals previously... ► Artikel lesen | |
| 23.05.25 | Chordate Medical Holding AB: Chordate Medical Holding AB (publ) Interim Report January-March 2025 | 247 | GlobeNewswire (Europe) | Summary of the period January-March 2025Net turnover was SEK 596,105 (257,677)Cash flow from operating activities was SEK -6,046,406 (-5,908,058)Profit/loss after financial items was SEK -5,756,609... ► Artikel lesen | |
| 28.03.25 | Chordate Medical Holding AB: Year-End Report Chordate Medical Holding AB (publ) January - December 2024 | 279 | GlobeNewswire (Europe) | Summary of the period October-December 2024Net turnover was SEK 86,076 (481,597)Cash flow from operating activities was SEK -4,659,856 (-7,501,648)Profit/loss after financial items was SEK -8,529,829... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,180 | -0,06 % | Mehr Dividende, mehr Gewinn: Darum kann Fresenius nicht punkten | Die Fresenius Aktie steht zu Beginn des Handelstages unter Abgabedruck: Auch wenn die Pharmasparte Kabi und das Krankenhausgeschäft gut laufen und dem DAX-Konzern für 2025 zu soliden Ergebnissen verholfen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,680 | +4,02 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,150 | -0,91 % | Börse am Morgen: AMD, E.On, FMC, Indus, Nvidia, Anthropic - Nord/LB Marktbericht | Das Verbrauchervertrauen in den USA hat sich im Februar überraschend aufgehellt. Das Barometer für die Konsumlaune stieg um 2,2 Punkte auf 91,2 Zähler, wie das Conference Board mitteilte. Befragte Ökonomen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,960 | +3,78 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,550 | 0,00 % | Firefly Neuroscience Skyrockets - Brain Scan Breakthrough Fuels Rally | ||
| CARL ZEISS MEDITEC | 25,880 | +2,05 % | Carl Zeiss Meditec-Aktie: Überraschende Erholung - Was steckt dahinter? | ||
| GERRESHEIMER | 17,150 | +6,46 % | Shortseller-Positionen aktuell: Auto1, FMC, Gerresheimer, Hensoldt, Nagarro, TeamViewer, Zalando | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BILLIONTOONE | 80,42 | 0,00 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,860 | -1,77 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics |
Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| PROGYNY | 17,800 | +1,14 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| PROCEPT BIOROBOTICS | 26,600 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| OTTOBOCK | 58,00 | +1,40 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock investiert in Zukunftstechnologie von Blue Arbor Technologies, Inc. | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Ottobock investiert in Zukunftstechnologie von Blue Arbor Technologies, Inc.
26.02.2026... ► Artikel lesen | |
| UNITEDHEALTH | 250,80 | +0,74 % | UnitedHealth-Aktie: Erholung in Sicht - Was Anleger jetzt wissen müssen | ||
| ECKERT & ZIEGLER | 15,210 | +3,54 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler kooperiert mit Molecular Partners bei der Entwicklung von Radio-DARPin-Therapeutika | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Kooperation/Vereinbarung
Eckert & Ziegler kooperiert mit Molecular Partners bei der Entwicklung von Radio-DARPin-Therapeutika
26.02.2026... ► Artikel lesen | |
| ESSILORLUXOTTICA | 221,40 | +2,55 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für EssilorLuxottica mit einem Kursziel von 355 Euro auf "Overweight" belassen. Nutzzahlen zeigten, dass Smartglasses... ► Artikel lesen |
CHORDATE MEDICAL HOLDING AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -97,27 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHORDATE MEDICAL HOLDING AB finden Sie auf Wallstreet Online.